Hypertension and concurrent arrhythmias

被引:15
作者
Lombardi, F [1 ]
Terranova, P [1 ]
机构
[1] Univ Milan, Osped San Paolo, Dipartimento Med Chirurg & Odontoiatria, I-20142 Milan, Italy
关键词
D O I
10.2174/1381612033454496
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Hypertension and cardiac arrhythmias commonly coexist in many patients. In this review, we will initially discuss arrhythmogenesis in hypertension, with particular emphasis on atrial and ventricular tachyarrhythmias and sudden cardiac death, whilst in the-final part, we will focus our attention on the effects of anti-hypertensive therapies on supra-ventricular and ventricular arrhythmias and on sudden cardiac death prevention. Many patients with atrial fibrillation or frequent premature ventricular contractions have hypertension, and both need to be managed appropriately. Furthermore, hypertensive left ventricular hypertrophy could cause a wide variety of ventricular arrhythmias, which could end in sudden cardiac arrest. Most anti-hypertensive therapies, such as the beta-blockers or ACE inhibitors, by slowing or interrupting the progression towards atrial and ventricular remodelling might exert some anti-arrhythmic effect, thus reducing the risk of sudden cardiac death in these patients.
引用
收藏
页码:1703 / 1713
页数:11
相关论文
共 103 条
[1]   HEART-RATE-VARIABILITY FROM 24-HOUR ELECTROCARDIOGRAPHY AND THE 2-YEAR RISK FOR SUDDEN-DEATH [J].
ALGRA, A ;
TIJSSEN, JGP ;
ROELANDT, JRTC ;
POOL, J ;
LUBSEN, J .
CIRCULATION, 1993, 88 (01) :180-185
[2]  
*ALLHAT OFF COORD, 2002, JAMA-J AM MED ASSOC, V288, P2981, DOI DOI 10.1001/JAMA.288.23.2981
[3]  
[Anonymous], 1985, J Hypertens, V3, P379
[4]  
[Anonymous], 1991, JAMA, V265, P3255
[5]   USEFULNESS OF ECHOCARDIOGRAPHIC LEFT-VENTRICULAR HYPERTROPHY, VENTRICULAR-TACHYCARDIA AND COMPLEX VENTRICULAR ARRHYTHMIAS IN PREDICTING VENTRICULAR-FIBRILLATION OR SUDDEN CARDIAC DEATH IN ELDERLY PATIENTS [J].
ARONOW, WS ;
EPSTEIN, S ;
KOENIGSBERG, M ;
SCHWARTZ, KS .
AMERICAN JOURNAL OF CARDIOLOGY, 1988, 62 (16) :1124-1125
[6]   Compensated cardiac hypertrophy: Arrhythmogenicity and the new myocardial phenotype .1. Fibrosis [J].
Assayag, P ;
Carre, F ;
Chevalier, B ;
Delcayre, C ;
Mansier, P ;
Swynghedauw, B .
CARDIOVASCULAR RESEARCH, 1997, 34 (03) :439-444
[7]   Risks and benefits of early treatment of acute myocardial infarction with an angiotensin-converting enzyme inhibitor in patients with a history of arterial hypertension: Analysis of the GISSI-3 database [J].
Avanzini, F ;
Ferrario, G ;
Santoro, L ;
Peci, P ;
Giani, P ;
Santoro, E ;
Franzosi, MG ;
Tognoni, G .
AMERICAN HEART JOURNAL, 2002, 144 (06) :1018-1025
[8]  
BENNETT WM, 1977, CLIN PHARMACOL THER, V22, P499
[9]  
BONARJEE VVS, 1995, BRIT HEART J, V73, P506
[10]   Amiodarone interaction with β-blockers -: Analysis of the merged EMIAT (European Myocardial Infarct Amiodarone Trial) and CAMIAT (Canadian Amiodarone Myocardial Infarction Trial) databases [J].
Boutitie, F ;
Boissel, JP ;
Connolly, SJ ;
Camm, AJ ;
Cairns, JA ;
Julian, DG ;
Gent, M ;
Janse, NJ ;
Dorian, P ;
Frangin, G .
CIRCULATION, 1999, 99 (17) :2268-2275